← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Mesoblast MESO $1.81B	37	+4	+12%	$10.3M
77	77 Pluri PLUR $11.9M	36	-6	-14%	$733K
78	GRML 78 Greenland Mines Ltd GRML $92.9M	34	+3	+10%	$101M
79	GRCL 79 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	33	+1	+3%	$98.3M
80	80 INmune Bio INMB $45.8M	33	-3	-8%	$11.7M
81	SGTX 81 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	33	-4	-11%	$8.5M
82	82 Capricor Therapeutics CAPR $423M	31	+2	+7%	$16.8M
83	83 Eterna Therapeutics ERNA $2.53M	31	-3	-9%	$2.44M
84	84 PharmaCyte Biotech PMCB $3.84M	31	-1	-3%	$12M
85	ACHL 85 DELISTED Achilles Therapeutics ACHL	28	+3	+12%	$61.6M
86	BLCM 86 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	28	-2	-7%	$2.13M
87	PTE 87 DELISTED PolarityTE, Inc. Common Stock PTE	27	-4	-13%	$327K
88	RCOR 88 DELISTED Renovacor, Inc. RCOR	27	+3	+13%	$18.4M
89	89 TScan Therapeutics TCRX $16.2M	26	+2	+8%	$29M
90	90 Benitec Biopharma BNTC $295M	25	+4	+19%	$5.92M
91	91 Candel Therapeutics CADL $682M	25	+2	+9%	$19.1M
92	92 Abeona Therapeutics ABEO $266M	24	-18	-43%	$3.62M
93	93 BioCardia BCDA $14.2M	23	-3	-12%	$3.17M
94	94 Estrella Immunopharma ESLA $23.3M	23	+1	+5%	$34.3M
95	ONCS 95 DELISTED OncoSec Medical Incorporated ONCS	23	-2	-8%	$2.51M
96	96 DELISTED Scorpius Holdings, Inc. SCPX	23	-2	-8%	$4.24M
97	97 Senti Biosciences Holdings SNTI $8.14M	23	+1	+5%	$27.8M
98	98 DELISTED Orgenesis Inc. Common Stock ORGS	22	+1	+5%	$2.28M
99	99 Imunon IMNN $5.95M	21	-3	-13%	$818K
100	100 Calidi Biotherapeutics CLDI $2.25M	20	-21	-51%	$36.1M